# DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE
> **ANDA219755** · Abbreviated New Drug Application (Generic) · Sponsor: INVENTIA HEALTHCARE LIMITED · Approved 2026-04-09
## Drug
- **FDA Application Number:** ANDA219755
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE
- **Generic name:** Dapagliflozin, Metformin Hydrochloride
- **Active ingredients:** DAPAGLIFLOZIN, METFORMIN HYDROCHLORIDE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** —
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** INVENTIA HEALTHCARE LIMITED
- **First approval:** 2026-04-09
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219755)
---
*MORVS · CC0 1.0*